… In this review, we examine the main mouse models of atherosclerosis currently available,
their method … The aim is to identify which, if any, mouse model of atherosclerosis is suitable for …

… and atherosclerosis lesions in apoE-/- mice, while the same anti-PCSK9 treatment could
reduce circulating TC and TG and attenuate atherosclerotic lesions in another mouse model, …

… atherosclerotic plaques in the 1980s. The new immunologic tools together with genetically …
mouse models laid the foundation for deciphering the inflammatory etiology of atherosclerosis …

… mouse models of atherosclerosis, liraglutide has been demonstrated to result in a body-weight–independent
decrease in atherosclerotic … Moreover, liraglutide treatment of ApoE−/− mice …

… [51] using a model of apoe −/− mice transplanted with bone marrow from animals deficient …
reduced development of atherosclerosis in both models, when compared to control mice. The …

… The basic pathology of atherosclerosis is described below because this issue has seldom
… are using mouse models. The pathological descriptions of human atherosclerosis were first …

… In summary, this novel mouse model is of considerable clinical relevance for evaluation of
anti-atherosclerotic drugs by targeting both hypercholesterolemia and hypertriglyceridemia. …

… was found to markedly reduce TF expression in atherosclerotic plaques [43]. Mouse
models of atherosclerosis have also been used extensively to study atherosclerosis [40]. …

… associated with increased atherosclerosis. B cell autoimmunity can also contribute to
atherosclerosis; for example, some mouse models of lupus show increased atherosclerosis ( …

… Taken together, these results indicated that EPC-derived exosomes ameliorated atherosclerotic
endothelial dysfunction in a mouse model of atherosclerotic diabetes. Thus, the present …